Hypoxic-Ischaemic Encephalopathy Completed Phase 1 / 2 Trials for Erythropoietin (DB00016)

Also known as: Encephalopathy, Hypoxic-Ischemic / Hypoxic-Ischemic Encephalopathy / Hypoxic ischemic encephalopathy [HIE], unspecified / Hypoxic ischemic brain injury

IndicationStatusPhase
DBCOND0080116 (Hypoxic-Ischaemic Encephalopathy)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00945789Erythropoietin in Infants With Hypoxic Ischemic Encephalopathy (HIE)Treatment
NCT00808704Neurological Outcome After Erythropoietin Treatment for Neonatal EncephalopathyPrevention